CORT- Corcept Therapeutics Incorporated

Name: Corcept Therapeutics Incorporated Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Corcept Therapeutics Incorporated (CORT) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. CORT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Baker G Leonard Jr	1.12M	$58.68M	-
Dir	Wilson James N	1.10M	$57.38M	-
Other	Guyer William	22.2K	$1.16M	-
Dir	Alton Gregg H	15.0K	$784.2K	-
Dir	Park Kimberly	15.0K	$784.2K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 2, 2025	Belanoff Joseph K78	Chief Executive Officer	Sell	40,000	$72.90	$2,915,921.75	-0.7%	-7.7%	-
May 2, 2025	Maduck Sean51	See Remarks	Sale+OE	39,410	$72.13	$2,842,769.23	-13.3%	-7.7%	-
May 1, 2025	Lyon Joseph Douglas48	See Remarks	Sale+OE	9,350	$71.96	$672,781.12	-50.9%	-2.2%	-
Apr 10, 2025	Swisher Daniel N Jr49	Director	Sale+OE	2,200	$70.22	$154,484.00	-100%	+4.7%	-38.1%
Apr 1, 2025	Guyer William	Chief Development Officer	Sale+OE	678	$114.51	$77,639.00	-11.0%	-20.2%	-54.3%
Apr 1, 2025	Belanoff Joseph K78	Chief Executive Officer	Sell	35,452	$94.92	$3,365,009.94	-0.6%	-20.2%	-54.3%
Apr 1, 2025	Maduck Sean51	See Remarks	Sale+OE	100,590	$100.62	$10,121,593.92	-21.4%	-20.2%	-54.3%
Apr 1, 2025	Lyon Joseph Douglas48	See Remarks	Sale+OE	200,650	$100.51	$20,167,953.55	-71.7%	-20.2%	-54.3%
Mar 24, 2025	Lyon Joseph Douglas48	See Remarks	Sale+OE	421	$60.58	$25,504.18	-4.5%	+24.9%	-43.1%
Mar 24, 2025	Belanoff Joseph K78	Chief Executive Officer	Sell	1,974	$60.83	$120,084.14	-	+24.9%	-43.1%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC